<DOC>
	<DOC>NCT01948219</DOC>
	<brief_summary>The objective of this clinical study is to evaluate the feasibility, safety and efficacy of the ENTegral Artificial Larynx (AL) in patients indicated for total laryngectomy.</brief_summary>
	<brief_title>ENTegral Clinical Trial</brief_title>
	<detailed_description />
	<criteria>Age more than or equal to 18 years old Is indicated for total laryngectomy (first intention) Must be able to comply with study requirements Must be able to understand and be willing to provide written informed consent Any condition that precludes the implantation of the ENTegral AL Existing coagulation disorder Contraindication for general anesthesia Tumoral extension outside of the larynx invading through extralaryngeal structures Previous radiotherapy Lifeexpectancy &lt; 12 months Be pregnant of breastfeeding or intention to becoming pregnant during study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>